Drug General Information |
Drug ID |
DXL0XK
|
Drug Name |
SID4243681
|
Synonyms |
CHEMBL1477311
|
Indication |
Discovery agent
|
Investigative |
[1]
|
Formula |
C26H24N4O3
|
Canonical SMILES |
O=C(N1CCN(CC1)c2ccccc2)c3ccc(CN4C(=O)Nc5ccccc5C4=O)cc3
|
InChI |
InChI=1S/C26H24N4O3/c31-24(29-16-14-28(15-17-29)21-6-2-1-3-7-21)20-12-10-19(11-13-20)18-30-25(32)22-8-4-5-9-23(22)27-26(30)33/h1-13H,14-18H2,(H,27,33)
|
InChIKey |
IGDCKRNSWXEZDI-UHFFFAOYSA-N
|
Target and Pathway |
Target(s) |
Estrogen receptor beta |
Target Info |
|
[1]
|
mRNA of androgen receptor |
Target Info |
|
[1]
|
KEGG Pathway
|
Estrogen signaling pathway
|
Prolactin signaling pathwayhsa04114:Oocyte meiosis
|
Pathways in cancer
|
Prostate cancer
|
NetPath Pathway
|
EGFR1 Signaling Pathway
|
AndrogenReceptor Signaling Pathway
|
FSH Signaling Pathway
|
Pathway Interaction Database
|
Plasma membrane estrogen receptor signaling
|
Validated nuclear estrogen receptor beta network
|
Validated nuclear estrogen receptor alpha networksmad2_3nuclearpathway:Regulation of nuclear SMAD2/3 signaling
|
Coregulation of Androgen receptor activity
|
Regulation of Androgen receptor activity
|
Nongenotropic Androgen signaling
|
Regulation of nuclear beta catenin signaling and target gene transcription
|
FOXA1 transcription factor network
|
Notch-mediated HES/HEY network
|
Reactome
|
Nuclear Receptor transcription pathwayR-HSA-383280:Nuclear Receptor transcription pathway
|
Activated PKN1 stimulates transcription of AR (androgen receptor) regulated genes KLK2 and KLK3
|
WikiPathways
|
SIDS Susceptibility Pathways
|
Ovarian Infertility Genes
|
Integrated Pancreatic Cancer Pathway
|
Nuclear ReceptorsWP706:SIDS Susceptibility Pathways
|
Prostate Cancer
|
Integrated Breast Cancer Pathway
|
Nuclear Receptors
|
Androgen receptor signaling pathway
|
References |
REF 1 | URL: https://www.ebi.ac.uk/chembl/ The ChEMBL database in 2017 |